Abiraterone acetate for the treatment of castrate-refractory prostate cancer

Author： Caley Andrew   Staffurth John  

Publisher： Future Medicine

ISSN： 1745-509X

Source： Aging Health, Vol.9, Iss.1, 2013-02, pp. : 9-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonate therapy for the treatment of skeletal complications in patients with prostate cancer

By Harzstark Andrea L   Ryan Charles J   Small Eric J  

Aging Health, Vol. 2, Iss. 6, 2006-12 ,pp. : 943-954

Future Medicine

Access to resources Recommend Favorite

Screening for prostate cancer in the elderly

By Martinez Roxanne   Wilson Shandra  

Aging Health, Vol. 9, Iss. 4, 2013-08 ,pp. : 359-360

Future Medicine

Access to resources Recommend Favorite

Prostate cancer staging

By Stephens N J   Bharwani N   Heenan S D  

Imaging, Vol. 20, Iss. 2, 2008-06 ,pp. : 112-121

British Institute of Radiology

Access to resources Recommend Favorite

Emerging biomarkers in prostate cancer

By Troyer Dean  

Aging Health, Vol. 2, Iss. 4, 2006-08 ,pp. : 579-588

Future Medicine

Access to resources Recommend Favorite

Androgen treatment and prostate safety

By  

The Aging Male, Vol. 7, Iss. 1, 2004-01 ,pp. : 50-50

Informa Healthcare

Access to resources Recommend Favorite